$INSM 8-K SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure —Paul Hudson, Former CEO of Sanofi and Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health and Veteran Biopharma Finance Leader, Join as New Independent Directors—
05 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure —Sara Bonstein Will Step Down as CFO on October 30 After Nearly Seven Years of Dedicated Leadership—
06 Aug 2026	8-K: Results of Operations and Financial Condition
16 Jul 2026	8-K: Regulation FD Disclosure
15 May 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
07 Apr 2026	8-K: Regulation FD Disclosure; Other Events
23 Mar 2026	8-K: Regulation FD Disclosure; Other Events
19 Feb 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
09 Jan 2026	8-K: Regulation FD Disclosure
17 Dec 2025	8-K: Regulation FD Disclosure; Other Events
18 Nov 2025	8-K: Regulation FD Disclosure; Other Events
30 Oct 2025	8-K: Results of Operations and Financial Condition
12 Aug 2025	8-K: Regulation FD Disclosure; Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition
13 Jun 2025	8-K: Regulation FD Disclosure; Other Events
10 Jun 2025	8-K: Regulation FD Disclosure; Other Events
06 Jun 2025	8-K: Other Events
16 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition

Comments